Skip to main content
. 2018 May 4;61(1):149–157. doi: 10.1007/s12020-018-1609-1

Table 1.

The hormonal and metabolic characteristics of the patients included in this study

BMI Glucose (mg/dl) Insulin (µU/ml) LH (mIU/ml) FSH (mIU/ml) LH/FSH PRL (ng/ml) E2 (pg/ml) T (ng/ml) FTI Cortisol (µg/l) DHEAS (µg/ml) 17OHP (ng/ml) 17KS (mg/24 h) HOMA index SHBG (ng/ml)
All PCOS under study(mean ± SEM)
PCOS (n=71)
25.6 ± 0.3 88.2 ± 0.7 11.2 ± 0.5 12.3 ± 0.6 6.2 ± 0.1 2.1 ± 0.1 10.5 ± 0.4 56.3 ± 2.2 0.6 ± 0.04 19.2 ± 1.8 472.8 ± 17.8 0.9 ± 0.04 1.4 ± 0.08 11.3 ± 0.4 2.4 ± 0.1 42.6 ± 1.9
PCOS with menstrual cycle < 45 days (mean ± SEM)
PCOS (n=30)
25.7 ± 0.2 88.1 ± 1.3 10.9 ± 1.0 12.6 ± 0.9 6.2 ± 0.2 2.0 ± 0.1 10.4 ± 0.7 59.0 ± 0.3 0.6 ± 0.07 16.8 ± 2.0 484.2 ± 27.5 0.9 ± 0.07 1.4 ± 0.1 11.5 ± 0.6 2.4 ± 0.2 45.2 ± 3
PCOS with menstrual cycle > 45 days (mean ± SEM)
PCOS (n=41)
25.8 ± 0.3 88.2 ± 0.9 11.4 ± 0.7 13.2 ± 0.8 6.2 ± 0.2 2.2 ± 0.1 10.6 ± 0.6 54.3 ± 3.0 0.6 ± 0.05 20.9 ± 2.8 464.4 ± 23.8 0.97 ± 0.05 1.4 ± 0.1 11.1 ± 0.5 2.5 ± 0.1 40.6 ± 2.5